Plunkett Research Online: Osteologix Holdings PLC

OSTEOLOGIX HOLDINGS PLC (OLGXF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Osteologix Holdings PLC develops innovative pharmaceuticals for the treatment and prevention of diseases of bone and joint tissues. One of its product candidate, NB S101 (strontium malonate), is a novel pharmaceutical agent in clinical development for treatment of osteoporosis. It is currently in th.....



Osteologix Holdings PLC
Ticker: OLGXF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 804 747-6027
Fax:
Address: 3rd Floor, Europa House
Harcourt Centre
Harcourt Street
Dublin 2, Ireland

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
John BarberichChairman of the Board/Director
Enda KennyDirector
See More
Osteologix Holdings PLC develops innovative pharmaceuticals for the treatment and prevention of diseases of bone and joint tissues. One of its product candidate, NB S101 (strontium malonate), is a novel pharmaceutical agent in clinical development for treatment of osteoporosis. It is currently in th.....See More See More

Auditor: Weinberg & Company, P.A.
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2009
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: